| Theoretical investigations and density functional theory based quantitative structure–activity relationships model for novel cytotoxic platinum (IV) complexes HP Varbanov, MA Jakupec, A Roller, F Jensen, MS Galanski, BK Keppler Journal of Medicinal Chemistry 56 (1), 330-344, 2012 | 92 | 2012 |
| Synthesis and characterization of novel bis (carboxylato) dichloridobis (ethylamine) platinum (IV) complexes with higher cytotoxicity than cisplatin H Varbanov, SM Valiahdi, AA Legin, MA Jakupec, A Roller, MS Galanski, ... European journal of medicinal chemistry 46 (11), 5456-5464, 2011 | 92 | 2011 |
| Novel tetracarboxylatoplatinum (IV) complexes as carboplatin prodrugs HP Varbanov, SM Valiahdi, CR Kowol, MA Jakupec, MS Galanski, ... Dalton Transactions 41 (47), 14404-14415, 2012 | 90 | 2012 |
| A novel class of bis-and tris-chelate diam (m) inebis (dicarboxylato) platinum (IV) complexes as potential anticancer prodrugs HP Varbanov, S Göschl, P Heffeter, S Theiner, A Roller, F Jensen, ... Journal of medicinal chemistry 57 (15), 6751-6764, 2014 | 58 | 2014 |
| Comparative in vitro and in vivo pharmacological investigation of platinum (IV) complexes as novel anticancer drug candidates for oral application S Theiner, HP Varbanov, M Galanski, AE Egger, W Berger, P Heffeter, ... JBIC Journal of Biological Inorganic Chemistry 20, 89-99, 2015 | 56 | 2015 |
| Repositioning approved drugs for the treatment of problematic cancers using a screening approach HP Varbanov, F Kuttler, D Banfi, G Turcatti, PJ Dyson PloS one 12 (2), e0171052, 2017 | 52 | 2017 |
| Tumor microenvironment in focus: LA-ICP-MS bioimaging of a preclinical tumor model upon treatment with platinum(iv)-based anticancer agents S Theiner, C Kornauth, HP Varbanov, MS Galanski, S Van Schoonhoven, ... Metallomics 7 (8), 1256-1264, 2015 | 51 | 2015 |
| Prediction of logP for Pt (II) and Pt (IV) complexes: comparison of statistical and quantum-chemistry based approaches IV Tetko, HP Varbanov, MS Galanski, M Talmaciu, JA Platts, M Ravera, ... Journal of inorganic biochemistry 156, 1-13, 2016 | 49 | 2016 |
| The role of the equatorial ligands for the redox behavior, mode of cellular accumulation and cytotoxicity of platinum (IV) prodrugs S Göschl, HP Varbanov, S Theiner, MA Jakupec, MS Galanski, ... Journal of inorganic biochemistry 160, 264-274, 2016 | 46 | 2016 |
| Screening-based approach to discover effective platinum-based chemotherapies for cancers with poor prognosis HP Varbanov, F Kuttler, D Banfi, G Turcatti, PJ Dyson PloS one 14 (1), e0211268, 2019 | 37 | 2019 |
| Synthesis, characterization and biological activity of Pt (II) and Pt (IV) complexes with 5-methyl-5 (4-pyridyl)-2, 4-imidazolidenedione A Bakalova, H Varbanov, R Buyukliev, G Momekov, D Ferdinandov, ... European journal of medicinal chemistry 43 (5), 958-965, 2008 | 37 | 2008 |
| Multi-scale imaging of anticancer platinum (IV) compounds in murine tumor and kidney AA Legin, S Theiner, A Schintlmeister, S Reipert, P Heffeter, MA Jakupec, ... Chemical Science 7 (5), 3052-3061, 2016 | 36 | 2016 |
| Development and validation of liquid chromatography-based methods to assess the lipophilicity of cytotoxic platinum (IV) complexes MHM Klose, S Theiner, HP Varbanov, D Hoefer, V Pichler, MS Galanski, ... Inorganics 6 (4), 130, 2018 | 34 | 2018 |
| Oxaliplatin reacts with DMSO only in the presence of water HP Varbanov, D Ortiz, D Höfer, L Menin, MS Galanski, BK Keppler, ... Dalton Transactions 46 (28), 8929-8932, 2017 | 32 | 2017 |
| Impact of the equatorial coordination sphere on the rate of reduction, lipophilicity and cytotoxic activity of platinum (IV) complexes D Höfer, HP Varbanov, M Hejl, MA Jakupec, A Roller, MS Galanski, ... Journal of Inorganic Biochemistry 174, 119-129, 2017 | 28 | 2017 |
| Tetracarboxylatoplatinum (IV) complexes featuring monodentate leaving groups—A rational approach toward exploiting the platinum (IV) prodrug strategy D Höfer, HP Varbanov, A Legin, MA Jakupec, A Roller, MS Galanski, ... Journal of inorganic biochemistry 153, 259-271, 2015 | 23 | 2015 |
| The impact of whole human blood on the kinetic inertness of platinum (IV) prodrugs–an HPLC-ICP-MS study S Theiner, M Grabarics, L Galvez, HP Varbanov, NS Sommerfeld, ... Dalton Transactions 47 (15), 5252-5258, 2018 | 22 | 2018 |
| Novel Pt (II) and Pt (IV) complexes with 3-amino-5-methyl-5-(4-pyridyl)-2, 4-imidazolidenedione. Synthesis, physicochemical, chemometric and pharmacological investigation A Bakalova, H Varbanov, R Buyukliev, S Stanchev, G Momekov, D Ivanov Inorganica Chimica Acta 363 (7), 1568-1576, 2010 | 21 | 2010 |
| Palladium (II) complexes with 5-methyl-5-(4-pyridyl)-2, 4-imidazolidenedione: Synthesis, thermogravimetric and cytotoxic investigation A Bakalova, H Varbanov, R Buyukliev, G Momekov, D Ivanov Journal of thermal analysis and calorimetry 95 (1), 241-246, 2009 | 20 | 2009 |
| Platinum Complexes with 5‐Methyl‐5 (4‐pyridyl) hydantoin and Its 3‐Methyl Derivatives: Synthesis and Cytotoxic Activity–Quantitative Structure‐Activity Relationships A Bakalova, H Varbanov, R Buyukliev, G Momekov, D Ivanov, ... Archiv der Pharmazie 344 (4), 209-216, 2011 | 15 | 2011 |
Georgi MomekovDept. Pharmacology, Pharmacotherapy and Toxicology, Faculty of Pharmacy, MU-SofiaVerified email at pharmfac.mu-sofia.bg
